Head & Neck · 2020 · 19 citations · 21 references
MedicineOncologyPharmacotherapyChemotherapyOncology PharmacotherapyTumor ProgressionCancer ImmunotherapyCombination ChemotherapyMalignant NeoplasmsSquamous Cell CarcinomaToxicity ManagementCancer Combination TherapyCetuximab TherapyMetastatic Squamous Cell CarcinomaOverall Survival After RecurrencePhase Ii InvestigationPlatinum-based RegimensStudy PhaseTargeted Combination Chemotherapy
BACKGROUND: Methotrexate in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) has limited progression-free survival (PFS) benefit. We hypothesized that adding cetuximab to methotrexate improves PFS. METHODS: In the phase-Ib-study, patients with R/M SCCHN received methotrexate and cetuximab as first-line treatment. The primary objective was feasibility. In the phase-II-study patients were randomized to this combination or methotrexate alone (2:1). The primary endpoint was PFS. Secondary endpoints were overall survival (OS), toxicity, and quality of life (QoL). RESULTS: In six patients in the phase-Ib-study, no dose limiting toxicities were observed. In the phase II study, 30 patients received the combination and 15 patients methotrexate. In the phase-II-study median PFS was 4.5 months in the combination group vs 2.0 months in the methotrexate group (HR 0.37; P = .002). OS, toxicity, and QoL were not significantly different. CONCLUSION: Cetuximab with methotrexate improved PFS without increased toxicity in R/M SCCHN-patients.
21
N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text
Medicine, Oncology, Pharmacology +16
Jan B. Vermorken, José Trigo, Ricardo Hitt et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text
Medicine, Oncology, Pharmacology +16
Barbara Burtness, Meredith A. Goldwasser, William A. Flood et al. · Journal of Clinical Oncology · 2005 · 883 citations
Medicine, Oncology, Pharmacology +17